Panacea Biotec Limited has informed the Exchange regarding Resignation of Mr. Devender Gupta as Chief Financial Officer of the company w.e.f. December 15, 2025.

CFO resignedKey managerial personnel resignedManagement Changes View source PDF Explain this filing

PANACEABIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.2%Reaction day

₹377.50

prior close

₹378.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.4%+0.7% vs market

Pharmaceuticals peers, median of 156sector-0.2%+0.5% vs sector

On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 0.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

+0.1

15m

+0.4

30m

+0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.2-0.4+0.7-0.2+0.5

Next day

-2.5-0.5-2.0-0.4-2.1

-4.2-0.7-3.5-0.5-3.7

-5.7-1.3-4.4-0.4-5.3

-7.0-1.8-5.3-1.0-6.0

-7.8-2.3-5.5-1.4-6.5

-13.4-5.7-7.7-3.2-10.2

15d

-8.6-5.1-3.5-3.5-5.2

+4.8-4.3+9.0-2.9+7.6

-6.9-11.6+4.7-8.7+1.8

-13.1-8.4-4.7-9.8-3.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Panacea Biotec Limited has informed the stock exchange about the resignation of Mr. Devender Gupta from the position of Chief Financial Officer, effective December 15, 2025. The CFO is a key managerial personnel under the Companies Act, and his exit creates a vacancy in the company's top finance leadership. No reason for the resignation or details of a successor have been disclosed in this filing. Investors will likely watch for a subsequent announcement regarding the appointment of a new CFO.

Likely market impact

CFO exits at mid-to-senior level can be viewed as a leadership gap that may temporarily affect financial reporting continuity, though the impact depends on the reason for departure and how quickly a replacement is appointed.